HIV-1 drug resistance mutations are present in six percent of persons initiating antiretroviral therapy in Lusaka, Zambia

RL Hamers, M Siwale, CL Wallis, M Labib… - JAIDS Journal of …, 2010 - journals.lww.com
Objective: To assess the mutational patterns and factors associated with baseline drug-
resistant HIV-1 present at initiation of first-line antiretroviral therapy (ART) at 3 sites in …

[PDF][PDF] HIV-1 Drug Resistance Mutations Are Present in Six Percent of Persons Initiating Antiretroviral Therapy in Lusaka, Zambia

R Schuurman, AMJ Wensing… - J Acquir Immune Defic …, 2010 - academia.edu
Objective: To assess the mutational patterns and factors associated with baseline drug-
resistant HIV-1 present at initiation of first-line antiretroviral therapy (ART) at 3 sites in …

HIV-1 drug resistance mutations are present in six percent of persons initiating antiretroviral therapy in Lusaka, Zambia

RL Hamers, M Siwale, CL Wallis… - Journal of acquired …, 2010 - pubmed.ncbi.nlm.nih.gov
Objective To assess the mutational patterns and factors associated with baseline drug-
resistant HIV-1 present at initiation of first-line antiretroviral therapy (ART) at 3 sites in …

HIV-1 drug resistance mutations are present in six percent of persons initiating antiretroviral therapy in Lusaka, Zambia.

RL Hamers, M Siwale, CL Wallis, M Labib… - Journal of Acquired …, 2010 - europepmc.org
Objective To assess the mutational patterns and factors associated with baseline drug-
resistant HIV-1 present at initiation of first-line antiretroviral therapy (ART) at 3 sites in …

[PDF][PDF] HIV-1 drug resistance mutations are present in six percent of persons initiating antiretroviral therapy in Lusaka, Zambia

RL Hamers, M Siwale, CL Wallis, M Labib… - Drug-resistant HIV-1 in …, 2010 - dare.uva.nl
HIV-1 drug resistance mutations are present in six percent of persons initiating antiretroviral
therapy in Lusaka, Zambia Page 95 Chapter 5 HIV-1 drug resistance mutations are present in …

[PDF][PDF] HIV-1 drug resistance mutations are present in six percent of persons initiating antiretroviral therapy in Lusaka, Zambia

RL Hamers, M Siwale, CL Wallis, M Labib… - Drug-resistant HIV-1 in …, 2010 - pure.uva.nl
HIV-1 drug resistance mutations are present in six percent of persons initiating antiretroviral
therapy in Lusaka, Zambia Page 95 Chapter 5 HIV-1 drug resistance mutations are present in …

HIV-1 drug resistance mutations are present in six percent of persons initiating antiretroviral therapy in Lusaka, Zambia.

RL Hamers, M Siwale, CL Wallis, M Labib, R Hasselt… - 2010 - cabidigitallibrary.org
Objective: To assess the mutational patterns and factors associated with baseline drug-
resistant HIV-1 present at initiation of first-line antiretroviral therapy (ART) at 3 sites in …

HIV-1 Drug Resistance Mutations Are Present in Six Percent of Persons Initiating Antiretroviral Therapy in Lusaka, Zambia

RL Hamers, M Siwale… - Journal of …, 2010 - researchinformation.amsterdamumc …
Objective: To assess the mutational patterns and factors associated with baseline drug-
resistant HIV-1 present at initiation of first-line antiretroviral therapy (ART) at 3 sites in …

[PDF][PDF] HIV-1 Drug Resistance Mutations Are Present in Six Percent of Persons Initiating Antiretroviral Therapy in Lusaka, Zambia

R Schuurman, AMJ Wensing… - J Acquir Immune …, 2010 - scholar.archive.org
Objective: To assess the mutational patterns and factors associated with baseline drug-
resistant HIV-1 present at initiation of first-line antiretroviral therapy (ART) at 3 sites in …

[PDF][PDF] HIV-1 Drug Resistance Mutations Are Present in Six Percent of Persons Initiating Antiretroviral Therapy in Lusaka, Zambia

R Schuurman, AMJ Wensing… - J Acquir Immune Defic …, 2010 - Citeseer
Objective: To assess the mutational patterns and factors associated with baseline drug-
resistant HIV-1 present at initiation of first-line antiretroviral therapy (ART) at 3 sites in …